Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 2, 2023
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
Terence Flynn Maintained (UTHR) at Buy with Decreased Target to $314 on, Nov 2nd, 2023
Terence Flynn of Morgan Stanley, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Decreased Target from $318 to $314 on, Nov 2nd, 2023.
Terence has made no other calls on UTHR in the last 4 months.
There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Terence's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Terence
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, August 3rd, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $268 on, Thursday, August 3rd, 2023
